olaparib,pembrolizumab
astrazeneca,merck
['olaparib', 'pembro']
 phase ll clinical trial of olaparib plus pembrolizumab in the treatment of patients with advanced biliary tract cancer. research by james o bryan, , , , , , and others . poster #408 #asco23 
Fighting a Smarter War on Cancer at the Otto J. Ruesch Center for the Cure of Gastrointestinal Cancers at Georgetown Lombardi Comprehensive Cancer Center.